Skip to content
Home › 13F recaps › Q3 2026 › ALNY

Which funds bought or sold ALNY in Q3 2026?

Alnylam Pharmaceuticals Inc. 9 funds bought, 3 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$2.7B.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold ALNY, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (9)

FundChangeEst. $Now
T. Rowe Price
Asset manager
Added+77.4%+$1.1B$2.5B
Baillie Gifford
Growth / crossover
Added+125.1%+$753M$1.4B
Capital World
Asset manager
Added+24%+$660M$3.4B
Wellington
Asset manager
Added+64.8%+$338M$858M
Capital Research
Asset manager
Added+12.2%+$294M$2.7B
AQR
Quant & multi-strategy
Added+133.5%+$240M$419M
Bank of America
Bank & broker
Added+74.2%+$182M$427M
Brown Advisory
Asset manager
Added+901%+$172M$191M
Dodge & Cox
Value investor
Added+2.6%+$13M$495M

Sold (3)

FundChangeEst. $Now
Fidelity
Asset manager
Trimmed-16%−$593M$3.1B
Two Sigma
Quant & multi-strategy
Trimmed-54.8%−$254M$209M
QRT
Quant & multi-strategy
Trimmed-84.9%−$167M$30M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.